CoChat

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Chronic Glucocorticoid Exposure Potentiates Placental Chorionic Plate Artery Constriction: Implications for Aberrant Fetoplacental Vascular Resistance in Fetal Growth Restriction

Abstract

Fetal growth restriction (FGR) is a serious pregnancy complication, resulting in significant perinatal morbidity and mortality. Increased vascular resistance in the fetoplacental circulation is a hallmark of FGR and is associated with enhanced vasoconstriction of the resistance arteries in the placenta, the chorionic plate arteries (CPAs). Although the cause is unknown, FGR is associated with excess exposure to glucocorticoids (GCs), key mediators of vascular resistance in the systemic circulation. We hypothesized that GCs alter CPA reactivity, thereby contributing to the altered blood flow dynamics seen in FGR. We aimed to examine the acute and chronic effects of GCs on CPA reactivity and the operational mechanisms. Glucocorticoid receptors were highly expressed by CPA. 11β-Hydroxysteroid isoenzyme type 2 was detected within the endothelium, whereas 11β-hydroxysteroid isoenzyme type 1 was absent. Acute GC treatment significantly attenuated U46619-induced constriction. This effect was reversed by cotreatment with mifepristone or an endothelial NOS inhibitor. In contrast, chronic GC treatment potentiated U46619 constriction in a dose-dependent manner, which was partially abolished by mifepristone cotreatment. Similar effects were observed using a novel nonsteroidal glucocorticoid receptor-specific agonist. Chronic treatment with GCs altered the expression of several vasoactive factors, including thromboxane and bradykinin receptors, prokineticin-1, cyclooxygenase-2, and endothelial NOS. In summary, acute and chronic GC treatment exerts contrasting effects on CPA vasoreactivity. These opposing effects are consistent with temporal actions in other vascular beds and reflect activation of distinct nongenomic and genomic pathways. Chronic exposure to elevated GCs may contribute to the raised vascular resistance observed in the fetoplacental circulation in FGR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2012-1927

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 2

  1. Perinatal and Maternal Mortality Review Committee, 2011, Fifth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting Mortality 2009
  2. Chrousos, 2006, Adrenocorticoids and adrenocortical antagonists, 635

Cited by

See all 33

Metadata

Authors
Nugent, J. L., Wareing, M., Palin, V., Sibley, C. P., Baker, P. N., Ray, D. W., Farrow, S. N., & Jones, R. L.
Affiliations
  • University of Manchester (GB)
  • Maternal and Fetal Health Research Centre (J.L.N., M.W., V.P., C.P.S., R.L.J.)
  • University of Auckland (NZ)
  • Manchester Academic Health Science Centre (GB)
Corresponding author
Jones, R. L.
Venue
Endocrinology
Published
2013-01-07
Volume
154
Issue
2
Pages
876-887
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2008362733
Cited by
33
References
50
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 4
FWCI
4.85
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Funders
  • GlaxoSmithKline
  • Action Medical Research
  • National Institute for Health and Care Research
  • Manchester Biomedical Research Centre
  • Medical Research Council
  • Engineering and Physical Sciences Research Council (EP/I037253/1)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords
fetal growth restriction, glucocorticoids, glucocorticoid receptor, 11β-hydroxysteroid dehydrogenase type 2, endothelial nitric oxide synthase, mifepristone, thromboxane receptor, bradykinin receptors, prokineticin 1, cyclooxygenase-2
MeSH terms
Arteries, Carbenoxolone, Chorion, Dexamethasone, Female, Fetal Growth Retardation, Glucocorticoids, Humans, Hydrocortisone, Placenta, Pregnancy, Vasoconstriction, Vasodilation, Mifepristone, 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid, Placental Circulation, 11-beta-Hydroxysteroid Dehydrogenases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic Glucocorticoid Exposure Potentiates Placental Chorionic Plate Artery Constriction: Implications for Aberrant Fetoplacental Vascular Resistance in Fetal Growth Restriction. https://app.cochat.ai/papers/10.1210/en.2012-1927
The paper
Nugent, J. L., Wareing, M., Palin, V., Sibley, C. P., Baker, P. N., Ray, D. W., Farrow, S. N., & Jones, R. L. (2013). Chronic Glucocorticoid Exposure Potentiates Placental Chorionic Plate Artery Constriction: Implications for Aberrant Fetoplacental Vascular Resistance in Fetal Growth Restriction. Endocrinology. https://doi.org/10.1210/en.2012-1927

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.